Search

everythinglearnresearchcommunity

for

Search:↓

DHT stops hair regrowth in mice, similar to human hair loss.

Some dibenzo compounds might help treat cancer with fewer side effects.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

SARM-induced changes in the androgen receptor are specific to each ligand and affect stability and protein interactions.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Estrogen therapy can reduce skin aging but has cancer risks.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

SARMs show promise but need more evidence to prove they're better than traditional androgens.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Birth control pills can help reduce mild to moderate acne in women.